Metabolic disturbance and impaired CD8+ T‐cell responses are the two major characteristics of HCV infection among different populations worldwide.[6, 8, 16] Although most patients with HCV infection who are receiving DAA treatment have a high SVR, metabolic disturbance is still associated with a high risk of liver disease progression and cancer development after high SVR. This evidence concerns the gene CD8A and cancer.